An Initial Test of Prototype Mobile App Interventions for Decluttering

February 20, 2024 updated by: Jennifer Krafft, Mississippi State University

The Impact of Values Clarification on Motivation to Declutter in People With Hoarding Problems: A Randomized Control Trial of a Prototype Mobile App Intervention

The aim of the study is to investigate whether values clarification writing prompts administered via a prototype mobile application can help enhance motivation and facilitate decluttering in individuals with hoarding problems. This randomized control trial will help to (1) assess whether values clarification can improve outcomes in hoarding treatment by increasing motivation, (2) clarify which specific values clarification procedures are most beneficial, and (3) evaluate the impact of values clarification on overall symptoms and well-being. Participants will be randomly assigned to either the experimental group (receiving the values clarification intervention), psychological placebo group (self-reflection intervention), or the no intervention waitlist group.

Study Overview

Detailed Description

This randomized control trial study aims to investigate the efficacy of a values clarification prototype mobile application intervention in enhancing motivation and facilitating decluttering in individuals with clinical levels of hoarding symptoms. Participants will be recruited using a variety of recruitment methods (e.g., Google Ads, posts on relevant online groups such as Facebook groups, posting flyers, and provider referrals). Interested participants will first complete a pre-screen asking about their age, country of residence, and whether they own an appropriate mobile device (i.e. iOS or Android). Eligible participants, who must be at least 18 years old and residing in the United States, will be provided with a consent form to sign and then directed to further screening to determine whether they meet the clinical cutoff for hoarding symptoms. Individuals who decline to participate or are screened as ineligible will be screened out and provided with a brief list of other resources they may access for clutter/hoarding problems. Individuals who consent and are screened as eligible will be redirected to complete a baseline survey and then randomly assigned to one of three groups with equal probability: (1) Experimental group with the values clarification mobile application, (2) psychological placebo group with the self-reflection mobile application, and (3) no-treatment waitlist group. Four weeks after baseline, participants will be asked to complete a post-treatment survey and eight weeks after baseline, participants will be asked to complete a final, follow-up survey. The no-treatment waitlist participants will be given the opportunity to download and use either prototype mobile app, and participants assigned to use one of the apps will be given the opportunity to use the alternative app.

Study Type

Interventional

Enrollment (Estimated)

124

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Mississippi
      • Starkville, Mississippi, United States, 39759
        • Recruiting
        • Mindfulness and Acceptance Processes Lab
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. 18 years or older.
  2. Living in the USA.
  3. Owning an Android or iOS mobile device.
  4. Meeting the clinical cutoff scores for the Saving Inventory-Revised and Clutter Image Rating scales.
  5. Seeking help for clutter and/or hoarding.
  6. Interested in testing a self-help prototype mobile app intervention.

Exclusion Criteria:

  1. 17 years or younger.
  2. Living outside the USA.
  3. Not owning an Android or iOS mobile device.
  4. Scoring below the clinical cutoff scores for the Saving Inventory-Revised and Clutter Image Rating scales.
  5. Not seeking help for clutter and/or hoarding.
  6. Not interested in testing a self-help prototype mobile app intervention.
  7. Not having the fluency in English sufficient to understand study materials.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Values Clarification Condition
Participants will be asked to respond to values clarification prompts twice a day over 28 days [4 weeks]. In each session, participants will receive a randomly assigned writing prompt from a pool of four categories: hierarchical, conditional, distinction, and perspective-taking prompts. In the initial session, participants will be asked to respond to a brief set of questions pertaining to their hoarding behavior in the past 12 hours and their motivation to declutter right now. From that point on, participants will respond to a brief set of questions before each writing prompt pertaining to their hoarding behaviors in the time since the previous writing prompt. After the writing prompt, they will be asked about how motivated they are to declutter right now. Each writing prompt is anticipated to take up to 10 minutes to complete and participants will receive notifications to use the app twice daily in addition email reminders twice a week to engage with the app.
Participants in the intervention group will be asked to answer a series of values clarification writing prompts twice a day over four weeks.
Placebo Comparator: Self-Reflection Condition
Participants in this condition will be asked to respond to a set of randomly selected self-reflection prompts twice a day over 28 days [4 weeks]. As with the experimental condition, participants in the initial session will be asked to respond to a brief set of questions pertaining to their hoarding behavior in the past 12 hours and their motivation to declutter right now. From that point on, participants will be asked to respond to a brief set of questions before each writing prompt pertaining to their hoarding behaviors in the time since the previous writing prompt. After the writing prompt, they will be asked about how motivated they are to declutter right now. Each writing prompt is anticipated to take up to 10 minutes to complete, and participants will receive notifications to use the app twice daily in addition to email reminders twice a week to engage with the app.
Participants in the psychological placebo group will be administered writing prompts in the same format and frequency as the values intervention, but with prompts focused on self-reflection related to clutter and organization.
No Intervention: Waitlist Condition
Participants assigned to the waitlist will not receive access to any intervention for 8 weeks. After 8 weeks, they will receive access to either the values clarification or self-reflection mobile application.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Saving Inventory - Revised (SI-R; Frost et al., 2004)
Time Frame: Baseline, Posttreatment (4 weeks after baseline) and Follow-up (8 weeks after baseline)
A self-report measure of hoarding symptoms grouped into three factors: excessive acquisition, difficulty discarding, and clutter. The SI-R consists of 23 items that are rated on a scale from 0 (e.g., no distress) to 4 (e.g., extreme distress). Scores range from 0 to 92, with higher scores indicate greater endorsement of hoarding disorder symptoms.
Baseline, Posttreatment (4 weeks after baseline) and Follow-up (8 weeks after baseline)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clutter Image Rating (CIR; Frost et al., 2008)
Time Frame: Baseline, Posttreatment (4 weeks after baseline) and Follow-up (8 weeks after baseline)
A self-report measure of clutter. Participants are presented with nine pictures of three rooms (kitchen, bedroom, and living room) in progressively increasing stages of clutter and are asked to pick the picture that most resembles their living space. Participants scores can range from 1 (picture #1) to 9 (picture #9) per room, with higher numbers indicating rooms with greater levels of clutter.
Baseline, Posttreatment (4 weeks after baseline) and Follow-up (8 weeks after baseline)
Sheehan Disability Scale (Sheehan, Harnett-Sheehan, & Raj, 1996)
Time Frame: Baseline, Posttreatment (4 weeks after baseline) and Follow-up (8 weeks after baseline)
A self-report measure of functional impairment due to symptoms. It consists of 3 items rated on a scale from 0 (not at all) to 10 (extremely). Scores range from 0 to 30, with higher scores indicate greater impairment. This measure has been adapted to ask about disability related to hoarding.
Baseline, Posttreatment (4 weeks after baseline) and Follow-up (8 weeks after baseline)
Activities of Daily Living in Hoarding Scale (ADL-H; Frost et al., 2013)
Time Frame: Baseline, Posttreatment (4 weeks after baseline) and Follow-up (8 weeks after baseline)
A self-report measure of activities impaired by hoarding disorder. The ADL-H consists of 15 items rated on a scale from 0 (can do it easily) to 5 (unable to do). A "not applicable" response option is also provided. Total scores range from a minimum of 0 to a maximum of 75, with higher scores indicating greater impairment.
Baseline, Posttreatment (4 weeks after baseline) and Follow-up (8 weeks after baseline)
Values Clarity Questionnaire (VCQ; McLoughlin et al., unpublished manuscript)
Time Frame: Baseline, Posttreatment (4 weeks after baseline) and Follow-up (8 weeks after baseline)
A self-report scale that measures how well respondents understand and can articulate their values. The VCQ consists of 7 items rated on a scale from 1 (strongly disagree) to 5 (strongly agree). Total scores range from a minimum of 7 to a maximum of 35, with higher scores indicating higher levels of clarity, understanding, and articulation of one's own values.
Baseline, Posttreatment (4 weeks after baseline) and Follow-up (8 weeks after baseline)
Valuing Questionnaire (VQ; Smout et al., 2013)
Time Frame: Baseline, Posttreatment (4 weeks after baseline) and Follow-up (8 weeks after baseline)
A self-report questionnaire that measures the extent to which one is living in accordance with their values. The VQ consists of 10 items rated on a scale from 0 (not at all true) to 6 (completely true). Total scores range from 0 to 60, with higher scores indicating greater valued living.
Baseline, Posttreatment (4 weeks after baseline) and Follow-up (8 weeks after baseline)
Acceptance and Action Questionnaire for Hoarding (AAQH; Krafft et al., 2019)
Time Frame: Baseline, Posttreatment (4 weeks after baseline) and Follow-up (8 weeks after baseline)
A self-report measure of hoarding-related psychological inflexibility. The AAQH consists of 14 items rated on a scale from 1 (never true) to 7 (always true). Total scores range from 14 to 98, with higher scores indicating greater hoarding-related psychological inflexibility.
Baseline, Posttreatment (4 weeks after baseline) and Follow-up (8 weeks after baseline)
Depression, Anxiety, and Stress Scales (DASS-21; Henry & Crawford, 2005)
Time Frame: Baseline, Posttreatment (4 weeks after baseline) and Follow-up (8 weeks after baseline)
A self-report measure of symptoms related to depression, anxiety, and stress. The DASS-21 consists of 21 items rated on a scale from 0 (did not apply to me at all) to 3 (applied to me very much, or most of the time). Total scores range from 0 to 63, with higher scores indicating greater endorsement of depression, anxiety, and stress related symptoms.
Baseline, Posttreatment (4 weeks after baseline) and Follow-up (8 weeks after baseline)
Satisfaction with Life Scale (SWLS; Diener et al., 1985)
Time Frame: Baseline, Posttreatment (4 weeks after baseline) and Follow-up (8 weeks after baseline)
A self-report measure assessing one's satisfaction with their life as a whole. The SWLS consists of 5 items rated on a scale from 1 (strongly disagree) to 7 (strongly agree). Scores range from 5 to 35, with higher scores indicating greater life satisfaction.
Baseline, Posttreatment (4 weeks after baseline) and Follow-up (8 weeks after baseline)
Random responding question (used in e.g. Krafft & Levin, 2021)
Time Frame: Baseline, Posttreatment (4 weeks after baseline) and Follow-up (8 weeks after baseline)
Participants will be asked to choose one of the following statements that best describe their participation in the survey, noting that their answer does not impact their participation in the study in any way: "I answered every question carefully and honestly" (1); "I answered most questions carefully and honestly" (2); "I randomly responded and/or did not respond honestly to about half of the questions"(3); "I randomly responded and/or did not respond honestly to most questions"(4); and "I randomly responded and/or did not respond honestly to any questions"(5). Participants who score a 4 or 5 will be screened out for random responding.
Baseline, Posttreatment (4 weeks after baseline) and Follow-up (8 weeks after baseline)
Treatment Evaluation Inventory-Short Form (TEI-SF; Kelley et al., 1989)
Time Frame: Posttreatment (4 weeks after baseline)
A self-report measure of treatment acceptability. Only administered to the experimental and placebo conditions.The TEI-SF consists of 7 items rated from 1 (strongly disagree) to 5 (strongly agree). Scores range from 7 to 35, with higher scores indicating higher levels of endorsement for treatment acceptability.
Posttreatment (4 weeks after baseline)
System Usability Scale (SUS; Bangor et al., 2008)
Time Frame: Posttreatment (4 weeks after baseline)
A self-report measure of usability of a technological system. The SUS consists of 10 items rated on a scale from 1 (strongly disagree) to 5 (strongly agree). Scores are summed and doubled such that they range from 0 to 100 (as per the official scoring instructions), with high scores indicated greater usability. Only administered to the experimental and placebo conditions.
Posttreatment (4 weeks after baseline)
Credibility/Expectancy Questionnaire (CEQ; Devilly & Borkovec, 2000)
Time Frame: After using first website session (approximately 0-1 weeks after baseline)
A self-report measure of the perceived credibility of and expectations toward a treatment. Only administered to the experimental and placebo conditions. The CEQ consists of 6 items, 3 for Credibility and 3 for Expectancy. An average score ranging from 1 to 9 will be calculated for Credibility, with higher scores a greater perception of the intervention's credibility by the participants. For the expectancy component, an average percentage score will be calculated ranging from 0% to 100%, with higher percentages indicating more positive expectations towards the treatment.
After using first website session (approximately 0-1 weeks after baseline)
Novel satisfaction item 1
Time Frame: Posttreatment (4 weeks after baseline)
Participants will be asked an open-ended question to gather qualitative feedback on the intervention. Only assigned to the experimental and placebo conditions. The question is, "What did you like best about the prototype mobile app?"
Posttreatment (4 weeks after baseline)
Novel satisfaction item 2
Time Frame: Posttreatment (4 weeks after baseline)
Participants will be asked an open-ended question to gather qualitative feedback on the intervention. Only administered to the experimental and placebo conditions. The question is, "What was the most important thing you learned from the mobile app?"
Posttreatment (4 weeks after baseline)
Novel satisfaction item 3
Time Frame: Posttreatment (4 weeks after baseline)
Participants will be asked an open-ended question to gather qualitative feedback on the intervention. Only assigned to the experimental and placebo conditions. The question is, "What did you like least about the mobile app? Why did you like this the least?"
Posttreatment (4 weeks after baseline)
Novel satisfaction item 4
Time Frame: Posttreatment (4 weeks after baseline)
Participants will be asked an open-ended question to gather qualitative feedback on the intervention. Only assigned to the experimental and placebo conditions. The question is, "Do you have any other comments or suggestions regarding the mobile app?"
Posttreatment (4 weeks after baseline)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jennifer Krafft, PhD, Mississippi State University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2023

Primary Completion (Estimated)

October 31, 2024

Study Completion (Estimated)

October 31, 2024

Study Registration Dates

First Submitted

October 4, 2023

First Submitted That Met QC Criteria

October 27, 2023

First Posted (Actual)

October 30, 2023

Study Record Updates

Last Update Posted (Estimated)

February 22, 2024

Last Update Submitted That Met QC Criteria

February 20, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

We plan to share fully deidentified data sets. We will remove any potentially identifying information including unusual demographics or combinations of demographics removed, but all other variables will be available to other researchers, journals or officials on reasonable request.

IPD Sharing Time Frame

Within one year of the end of data collection, and remaining available indefinitely

IPD Sharing Access Criteria

There are no specific access criteria. The request must have a valid research-related purpose.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hoarding

Clinical Trials on Values Clarification Mobile Application

3
Subscribe